Jeon YK - Search Results

1

The transcription factor Mef2d regulates B:T synapse-dependent GC-T_FH differentiation and IL-21-mediated humoral immunity.

Kim YJ, Oh J, Jung S, Kim CJ, Choi J, Jeon YK, Kim HJ, Kim JW, Suh CH, Lee Y, Im SH, Crotty S, Choi YS. Kim YJ, et al. Among authors: jeon yk. Sci Immunol. 2023 Mar 31;8(81):eadf2248. doi: 10.1126/sciimmunol.adf2248. Epub 2023 Mar 24. Sci Immunol. 2023. PMID: 36961907 Free PMC article.

2

ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy.

Kim JW, Kim JH, Im SA, Kim YJ, Han HS, Kim JS, Han SW, Jeon YK, Oh DY, Han W, Kim TY, Park IA, Noh DY, Bang YJ. Kim JW, et al. Among authors: jeon yk. Oncology. 2012;83(4):218-27. doi: 10.1159/000341359. Epub 2012 Aug 16. Oncology. 2012. PMID: 22906996

3

Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study.

Jung M, Kim S, Lee JK, Yoon SO, Park HS, Hong SW, Park WS, Kim JE, Kim J, Keam B, Kim HJ, Kang HJ, Kim DW, Jung KC, Kim YT, Heo DS, Kim TM, Jeon YK. Jung M, et al. Among authors: jeon yk. Oncologist. 2019 Aug;24(8):e740-e748. doi: 10.1634/theoncologist.2018-0477. Epub 2019 Jan 29. Oncologist. 2019. PMID: 30696721 Free PMC article.

4

CRIF1 deficiency induces FOXP3^LOW inflammatory non-suppressive regulatory T cells, thereby promoting antitumor immunity.

Lee S, Song SG, Kim G, Kim S, Yoo HJ, Koh J, Kim YJ, Tian J, Cho E, Choi YS, Chang S, Shin HM, Jung KC, Kim JH, Kim TM, Jeon YK, Kim HY, Shong M, Kim JH, Chung DH. Lee S, et al. Among authors: jeon yk. Sci Adv. 2024 Mar 29;10(13):eadj9600. doi: 10.1126/sciadv.adj9600. Epub 2024 Mar 27. Sci Adv. 2024. PMID: 38536932 Free PMC article.

5

MHC class II-restricted interaction between thymocytes plays an essential role in the production of innate CD8+ T cells.

Min HS, Lee YJ, Jeon YK, Kim EJ, Kang BH, Jung KC, Chang CH, Park SH. Min HS, et al. Among authors: jeon yk. J Immunol. 2011 May 15;186(10):5749-57. doi: 10.4049/jimmunol.1002825. Epub 2011 Apr 8. J Immunol. 2011. PMID: 21478404 Free PMC article.

6

RELT negatively regulates the early phase of the T-cell response in mice.

Choi BK, Kim SH, Kim YH, Lee DG, Oh HS, Han C, Kim YI, Jeon Y, Lee H, Kwon BS. Choi BK, et al. Eur J Immunol. 2018 Oct;48(10):1739-1749. doi: 10.1002/eji.201847633. Epub 2018 Sep 2. Eur J Immunol. 2018. PMID: 30138536 Free article.

7

Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients.

Yoo SH, Keam B, Ock CY, Kim S, Han B, Kim JW, Lee KW, Jeon YK, Jung KC, Chung EJ, Kwon SK, Ahn SH, Sung MW, Heo DS. Yoo SH, et al. Among authors: jeon yk. Sci Rep. 2019 May 22;9(1):7680. doi: 10.1038/s41598-019-44206-2. Sci Rep. 2019. PMID: 31118488 Free PMC article.

8

Generation of PLZF+ CD4+ T cells via MHC class II-dependent thymocyte-thymocyte interaction is a physiological process in humans.

Lee YJ, Jeon YK, Kang BH, Chung DH, Park CG, Shin HY, Jung KC, Park SH. Lee YJ, et al. Among authors: jeon yk. J Exp Med. 2010 Jan 18;207(1):237-46. doi: 10.1084/jem.20091519. Epub 2009 Dec 28. J Exp Med. 2010. PMID: 20038602 Free PMC article.

9

Clinical significance of tumor-infiltrating FOXP3+ T cells in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.

Kim KH, Kim TM, Go H, Kim WY, Jeon YK, Lee SH, Kim DW, Khwarg SI, Kim CW, Heo DS. Kim KH, et al. Among authors: jeon yk. Cancer Sci. 2011 Nov;102(11):1972-6. doi: 10.1111/j.1349-7006.2011.02051.x. Epub 2011 Sep 6. Cancer Sci. 2011. PMID: 21812857 Free article.

10

HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer.

Kim JW, Kim JH, Im SA, Kim YJ, Han HS, Kim JS, Lee KH, Kim TY, Han SW, Jeon YK, Oh DY, Kim TY, Park IA. Kim JW, et al. Among authors: jeon yk. Cancer Chemother Pharmacol. 2013 Jul;72(1):109-15. doi: 10.1007/s00280-013-2174-1. Epub 2013 May 15. Cancer Chemother Pharmacol. 2013. PMID: 23673443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

440 results

Search Page